Enrollment change • Trial completion date • Trial termination • Trial primary completion date • Metastases
|
PD-L1 (Programmed death ligand 1) • BRAF (B-raf proto-oncogene) • IL2 (Interleukin 2)
|
BRAF mutation • BRAF V600
|
Opdivo (nivolumab) • ATL 001